Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC


10/29/2024

Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales  CNBCPfizer sales were boosted by a COVID-19 wave during the third quarter  QuartzPfizer Stock Rises After Earnings Beat, Guidance Hike  Barron'sPfizer profit up on COVID treatment sales as it faces activist pressure  ReutersPfizer raises full-year guidance by $1.5 billion amid activist investor pressure  Yahoo Finance...

Original

Categories: COVID | Earnings | Financial | Health | Stock

Tags: amid | beat | billion | cnbc | covid | covid-19 | earnings | faces | finance | guidance | profit | raises | rises | sales | stock | treatment | wave



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top